The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BARINTHUS BIOTHERAPEUTICS PL | ADS | 91864C107 | 423,855 | 642,204 | SH | SOLE | 642,204 | 0 | 0 | ||
| TSCAN THERAPEUTICS INC | COM | 89854M101 | 617,463 | 630,000 | SH | SOLE | 630,000 | 0 | 0 | ||
| WEREWOLF THERAPEUTICS INC | COM | 95075A107 | 212,018 | 589,102 | SH | SOLE | 589,102 | 0 | 0 | ||